Oppenheimer Forecasts Strong Price Appreciation for The Ensign Group (NASDAQ:ENSG) Stock

Key Points

• Oppenheimer raised its price target for The Ensign Group from $210 to $215 and maintained an “outperform” rating, implying 16.78% potential upside. Analysts overall rate the stock a “Moderate Buy,” with an average target of $216.60.
• Ensign reported quarterly earnings of $2.03 per share, beating estimates, while revenue rose 14.5% year over year to approximately $1.48 billion. The company also raised its 2026 earnings guidance.
• Despite strong operating results and substantial institutional ownership, Ensign faces securities-fraud litigation alleging patient-care, staffing, billing and licensing misconduct; the claims remain unproven and add legal and reputational risk.

The Ensign Group (NASDAQ:ENSG - Get Free Report) had its price objective hoisted by equities researchers at Oppenheimer from $210.00 to $215.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Oppenheimer's target price points to a potential upside of 16.78% from the company's previous close.

A number of other brokerages have also issued reports on ENSG. Royal Bank Of Canada reiterated an "outperform" rating and set a $228.00 target price on shares of The Ensign Group in a research report on Tuesday, July 28th. Truist Financial set a $210.00 price target on shares of The Ensign Group in a research note on Thursday. Weiss Ratings raised shares of The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Finally, Wall Street Zen upgraded shares of The Ensign Group from a "hold" rating to a "buy" rating in a research report on Sunday. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, The Ensign Group currently has a consensus rating of "Moderate Buy" and an average target price of $216.60.

The Ensign Group Trading Up 8.6%

Shares of The Ensign Group stock opened at $184.11 on Thursday. The Ensign Group has a 12-month low of $141.58 and a 12-month high of $218.00. The stock has a market capitalization of $10.73 billion, a P/E ratio of 28.86, a price-to-earnings-growth ratio of 1.66 and a beta of 0.66. The company has a 50-day simple moving average of $174.68 and a 200 day simple moving average of $181.50. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $2.03 EPS for the quarter, topping analysts' consensus estimates of $1.97 by $0.06. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.51 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The Ensign Group's revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.64 EPS. Research analysts expect that The Ensign Group will post 7.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in shares of The Ensign Group in the second quarter valued at approximately $937,218,000. Bank of New York Mellon Corp bought a new stake in shares of The Ensign Group during the second quarter worth $65,470,000. Paradigm Capital Management Inc. NY acquired a new stake in shares of The Ensign Group during the second quarter worth $54,742,000. Bank of America Corp DE acquired a new stake in shares of The Ensign Group during the second quarter worth $37,509,000. Finally, Wasatch Advisors LP lifted its position in The Ensign Group by 10.7% in the 2nd quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company's stock valued at $365,215,000 after acquiring an additional 220,329 shares in the last quarter. 96.12% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Ensign reported third-quarter adjusted earnings of $2.03 per share, exceeding consensus estimates near $1.94–$1.97 and rising from $1.64 a year earlier. Revenue increased 14.5% year over year to approximately $1.48 billion. Ensign Group third-quarter results
• Positive Sentiment: The company raised its 2026 annual earnings guidance, while UBS analyst A.J. Rice reiterated a Buy rating, citing strong operating trends and continued earnings-growth potential. UBS analyst rating
• Neutral Sentiment: Several law firms reminded investors of a December 7, 2026 deadline to seek lead-plaintiff status in a securities class action covering investors who purchased ENSG shares from February 10, 2022, through June 18, 2026. These notices largely repeat previously reported litigation developments rather than represent new operating news. Rosen securities lawsuit notice
• Negative Sentiment: A securities-fraud class action alleges that Ensign and certain executives concealed patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. The allegations followed reports and an approximately 8% stock decline, increasing legal, reputational, and potential financial risks. The claims have not been proven. BFA Law Ensign securities-fraud lawsuit notice

About The Ensign Group

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.